BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, March 19, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Oct. 17, 2016
View Archived Issues
BioWorld stock report for public biotechnology companies
Read More
The week's biggest gainers and losers
Read More
Money raised by biotech: Jan. 1 - Oct. 14, 2016
Read More
Money raised by biotech in 2016 vs. 2015
Read More
Regulatory submissions, approvals & other actions: September 2016
Read More
Phase III clinical trials update: September 2016
Read More
Phase II clinical trials update: September 2016
Read More
Phase I clinical trials update: September 2016
Read More
Cannabinoids medicalized for multiple indications
Marijuana has been used as a medical treatment for centuries. But there’s only one cannabinoid-based drug on the market, Marinol (dronabinol, Abbvie Inc.), which was approved back in 1985.
Read More
Week in review
Read More
Week in Washington
Read More
Word on the street
Read More
FDA approvals in September
Read More